ReviewOncotarget2017

Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression.

Massimo Giuliani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.